Entrada Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TRDA for the last quarter is 19.57 M USD, and it's 79.33% lower compared to the previous quarter. The net income of Q3 24 is -14.03 M USD.